MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
Obesity is closely linked to metabolic diseases, particularly non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD), ultimately leading to hepatocellular carcinoma (HCC). However, the molecular mechanisms of NASH-associated HCC (NAHCC) remain elusive. To explore the impac...
Main Authors: | Yi-Wen Tsai, Kuo-Shyang Jeng, Mu-Kuang He, Yang-Wen Hsieh, Hsin-Hung Lai, Chi-Yu Lai, Chun-Chieh Huang, Chiung-Fang Chang, Chung-Tsui Huang, Guor Mour Her |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/12/3434 |
Similar Items
-
MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
by: Chi-Yu Lai, et al.
Published: (2021-02-01) -
Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2−/− animals
by: Lozan Sheriff, et al.
Published: (2020-12-01) -
Inhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafish
by: Changwen Zhang, et al.
Published: (2016-11-01) -
Interrelation between fibrosis, angiogenesis and ductular reaction in progression of chronic steatohepatitis (alcoholic and non-alcoholic) and hepatitis C virus infection
by: O. M. Gavrilyuk
Published: (2014-08-01) -
Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patients
by: Thomas Monfeuga, et al.
Published: (2024-01-01)